Stable reversal of primitive intestinal lymphangiectasia

Rivista Italiana di Nutrizione Parenterale ed Enterale

Volumn 22, Issue 2, 2004, Pages 82-85

  Santarpia, L ^a   Alfonsi, L ^a   Genua, M ^a   D'Armiento, F B ^a   Contaldo, F ^a   Pasanisi, F ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Clinica e Sperimentale   (Italy)

Author keywords

Duodenal biopsies; Intestinal lymphangiectasia; MCT enriched diet; Protein losing enteropathy

Indexed keywords

MEDIUM CHAIN TRIACYLGLYCEROL;

ABDOMINAL PAIN; ADULT; CASE REPORT; CLINICAL FEATURE; CONFERENCE PAPER; DIARRHEA; DUODENUM BIOPSY; EDEMA; FEMALE; HUMAN; INTESTINE LYMPHANGIECTASIA; LOW FAT DIET; LYMPH VESSEL; MUCOSA; NUTRITIONAL REQUIREMENT; NUTRITIONAL SUPPORT; PROTEIN DIET; PROTEIN LOSING GASTROENTEROPATHY; SEROSA; SMALL INTESTINE; STEATORRHEA; SUBMUCOSA; VOMITING;

EID: 11144237935     PISSN: 03935582     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. Reisher TA, Strober W, Muchmore AV, et al. Corticosteroid-responsive intestinal lymphangiectasia secondary to an inflammatory process. N Engl J Med 1979; 300: 605-6.
2. Persic M, Browse NL, Pripic I. Intestinal lymphangiectasia and protein losing enteropathy responding to small bowel resection. Arch Dis Child 1998; 78: 194-6.
3. Ballinger AB, Farthing JG. Octreotide in the treatment of intestinal lymphangiectasia. Eur J Gastroenterol Hepatol 1998; 10: 699-702.
4. Bac DJ, Van Hagen PM, Postema PT, et al. Octreotide for protein-losing enteropathy with intestinal lymphangiectasia (letter). Lancet 1995; 345: 8965.
5. Kuroiwa G, Takayama T, Sato Y, et al. Primary intestinal lymphangiectasia successfully treated with octreotide. J Gastroenterol 2001; 36: 129-32.
6. Mine K, Matsubayashi S, Nakai Y, Nakagawa T. Intestinal lymphangiectasia markedly improved with antiplasmin therapy. Gastroenterology 1989; 96: 1596-9.
7. MacLean JE, Cohen E, Weinstein M. Primary intestinal and thoracic lymphangiectasia: a response to antiplasmin therapy. Pediatrics 2002; 109: 1177-80.
8. Munck A, Sosa Valencia G, et al. Long-term follow up of primary intestinal lymphangiectasia in the child. Six case reports. Arch Pediatr 2002; 9: 388-91.
9. Alfano V, Tritto G, Alfonsi L, Cella A, Pasanisi F, Contaldo F. Stable reversal of pathologic signs of primitive intestinal lymphangiectasia with a hypolipidic, MCT-enriched diet. Nutrition 2000; 16: 303-4.
10. Fox U, Lucani G. Disorders of the intestinal mesenteric lymphatic system. Lymphology 1993; 26: 61-6.
11. Mistilis SP, Skyring AP, Stephen DD. Intestinal lymphangiectasia: mechanism of enteric loss of plasma protein and fat. Lancet 1965; 42: 77-9.
12. Asakura H, Miura S, Morishita T, et al. Endoscopic and histopathological study on primary and secondary intestinal lymphangiectasia. Dig Dis Sci 1981; 26: 312-20.
13. Strober W, Wocher RD, Carbone PP, Waldman TA. Intestinal lymphangiectasia. A protein-losing enteropathy with hypogammaglobulinemia, lymphocytopenia and impaired homograft rejection. J Clin Invest 1967; 46: 1643-56.
14. Patel AS, De Ridder PH. Endoscopic appearance and significance of functional lymphangiectasia of duodenal mucosa. Gastrointest Endosc 1990; 36: 376-8.
15. Jeffries GH, Chapman A, Sleisenger MH. Low fat diet in intestinal lymphangiectasia: its effect on albumin metabolism. N Engl J Med 1964; 270: 761-6.